Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Statement [Abstract] | ||||
| Sales, net | $ 14,262 | $ 16,770 | $ 141,760 | $ 9,072,130 |
| Cost of goods sold | 12,330 | 11,984 | 83,290 | 466,802 |
| Gross profit | 1,932 | 4,786 | 58,470 | 8,605,328 |
| Operating Expenses: | ||||
| Product development | 215,575 | 94,223 | 1,373,351 | 693,448 |
| Sales and marketing | 349,251 | 86,264 | 811,537 | 215,332 |
| General and administrative, net | 5,109,473 | 5,845,775 | 26,638,816 | 17,238,184 |
| Transaction costs | 35,000 | 55,038,544 | ||
| Depreciation and amortization | 60,116 | 68,916 | 273,772 | 818,203 |
| Total operating expenses | 5,769,415 | 6,095,178 | 84,136,020 | 18,965,167 |
| Loss from operations | (5,767,483) | (6,090,392) | (84,077,550) | (10,359,839) |
| Other income (expense): | ||||
| Other income, net | 772 | 2,584 | 21,390 | 59,982 |
| UK R&D tax credit | 1,251,243 | |||
| Loss on initial issuance of convertible note | (1,770,933) | |||
| Change in fair value of convertible note option liability | 59,000 | 840,933 | ||
| Change in fair value of warrant liabilities | 420,497 | 200,124 | ||
| Change in fair value of Earn-out Share Liability | 10,530,000 | 38,040,000 | ||
| Other expense | 2,750 | (2,836) | (244,732) | (21,857) |
| Interest income | 1,942 | |||
| Interest expense | (946,484) | (456,768) | (1,808,243) | (5,318,817) |
| Total other income (expense) | 10,066,534 | (457,020) | 36,529,782 | (5,278,750) |
| Net income (loss) | $ 4,299,052 | $ (6,547,412) | $ (47,547,768) | $ (15,638,589) |
| Net income (loss) per share: | ||||
| Basic (in Dollars per share) | $ 0.12 | $ (0.31) | $ (1.88) | $ (0.97) |
| Diluted (in Dollars per share) | $ 0.12 | $ (0.31) | $ (1.88) | $ (0.97) |
| Weighted-average common stock outstanding used in per share amounts: | ||||
| Basic (in Shares) | 36,369,224 | 21,115,617 | 25,257,473 | 16,154,794 |
| Diluted (in Shares) | 36,583,665 | 21,115,617 | 25,257,473 | 16,154,794 |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustment | $ 20,411 | $ 365,381 | ||
| Comprehensive income (loss) | $ 4,319,462 | $ (6,182,031) | $ (46,752,023) | $ (17,071,977) |
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A credit or adjustment for government or taxing authority authorized decrease in taxes owed as a result of meeting certain tax policy conditions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of fair value adjustment of earn-out share liability. No definition available.
|
| X | ||||||||||
- Definition The amount of other expense. No definition available.
|
| X | ||||||||||
- Definition The amount of transaction costs incurred with contingent earn-out share liability. No definition available.
|